Yasungulwa ngo-2009, i-JYMed ingumhlinzeki wesevisi we-peptide we-CRDMO ohamba phambili kanye nomkhiqizi we-API ejwayelekile e-China egxile ekuhlanganiseni ngokwezifiso, ukuthuthukiswa kwenqubo, ukuhlinzekwa komtholampilo kanye nokudayiswa kwezinto ze-peptide. Le nkampani isebenzisa cishe ama-FTEs angu-600+, nethimba labaphathi eliwumgogodla elakhiwe ochwepheshe abanolwazi lweminyaka engaphezu kwengu-20 kubuchwepheshe be-peptide. I-JYMed isebenzisa isikhungo esisodwa se-R&D kanye nezindawo ezimbili ezinkulu zokukhiqiza ezinezinjongo eziningi, ezinamandla okukhiqiza ama-peptide angamathani amaningi.